Improvements in the diagnosis and gonadotoxic treatment (chemotherapy, radiotherapy and bone marrow transplantation or surgery) of children, adolescents and young adults and adult cancer patients of reproductive age (0-45 years) has led to significant improvements in survival rates. As survival rates improve, there is an expectation by clinicians and patients to preserve the reproductive health potential of patients who receive gonadotoxic treatment whenever possible.

The loss of reproductive function due to cancer or non-malignant diseases, treated with gonadotoxic treatment, is a significant survivorship consideration for many patients. The use of these treatment can affect the future fertility of men, women, and children and the late effects consequences of infertility can have a lasting impact on a patient’s physical and psychological well being. The term “oncofertility” describes a new subspecialty of medicine that focuses on the reproductive future for cancer survivors, who may face infertility as a result of their treatment.

The FUTuRE Fertility Research Program has a number of ongoing biological, physiological, psychological and socio-cultural research studies.

On this website you will find information about current research studies as well as oncofertility patient information.

Meet the Team

Current Research

Patient Stories


Latest News

  • Miracle baby born to cancer patient Marcus Ehrlich who lost his fertility.


  • Bron


  • Launch of FUTuRE Fertility Studies


Twitter Feeds